Oral Leukoplakia, Oral Lichen Planus, Premalignant Lesion
Conditions
Brief summary
Abstract Objective: To study the diagnostic efficiency of Rose Bengal with Toluidine blue in detecting the biopsy sites and thus establish an accurate diagnosis in oral premalignant lesions. Materials and method: In our study 27 patients with 41 lesions were included. Since one patient had not quit the habit in the two weeks following initial examination and another lesion disappeared in the waiting period, 2 patients (3 lesions) were not included in the study. Out of 38 lesions diagnosed based on clinical criteria, 32 were leukoplakia, 5 lichen planus and 1 SCC. After initial examination they were subjected to Rose Bengal and Toluidine blue stain. If stained positive they were subjected to biopsy.
Detailed description
Introduction Toluidine blue staining is the most common technique used for the early detection of dysplastic changes in patients with premalignant lesions. One meta-analysis of Rosenberg et al. previously published reported sensitivity ranged from 93.5% to 97.8% and the specificity ranged from 73.3% to 92.9%. Zang et al reported that TB not only detects high-grade dysplasia but detects OPLs with minimal or no dysplasia with high-risk clinical and molecular attributes.4 But, studies have shown as high as 30% risk of false-positive staining. Rose Bengal (RB) has been widely used to diagnose various ocular surface disorders including delineation of the extent of corneal and conjunctival neoplasms. It has been believed to stain desquamated ocular epithelial cells, dead or degenerated cells, or wherever there is poor protection of the surface epithelium by the preocular tear film rather than lack of cell vitality. These characteristic features of RB lead the researchers to apply it in oral premalignant lesions.5 In none of the studies, reliability of RB stains was not compared with existing or previously practiced methods in oral premalignant lesions. Hence this study was undertaken with the aim of comparing the RB and TB stain and for early detection of dysplasia in oral premalignant lesions. Materials and Methods: Study group consists of 41 oral premalignant lesions in patients visiting the Department of Oral Medicine and Radiology of The oxford dental college and hospital, Bangalore. Patients with OSMF, patients with bleeding disorders, patient with other systemic diseases were excluded from the study.To perform the present study, ethical clearance was obtained from the Institutional Ethical Board. Study procedure was explained and informed consent was taken from the selected patients with premalignant lesions. The patients with lesions were subjected to detailed case history, intra oral examination and photographs of the lesions were recorded. Patients with habits were counselled to quit the habit and recalled after 2 weeks for staining. Since one patient had not quit the habit in the two weeks from first visit, in another patient the lesion disappeared in two weeks 2 patients (3 lesions) were not included in the study. (Graph1) Initially patients were asked to rinse their mouth with distilled water for 1 minute. 1% RB solution was applied with a cotton tip for 2 minutes. Again patients were asked to rinse their mouth for 1 minute with distilled water to remove excess RB solution and the area which had taken up the stain was photographed. Following this, patients were asked to rinse their mouth with 1% acetic acid for 1 min to remove the remaining RB stain from the lesion and were prepared for TB staining. 1%Toluidineblue is applied over the lesion and after 30 seconds patients were made to swish with 1% acetic acid and the area stained was recorded photographically. These two photographs were assessed and if the stained area was similar in both the procedures single biopsy was taken. If the stained areas were different two different biopsies were taken.
Interventions
rose bengal stain and toluidine is applied over a premalignant lesion and positively stained lesions are subjected to biopsy.
the lesions stained positive were subjected to biopsy
the lesions stained positive were subjected to biopsy
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with clinically diagnosed oral premalignant lesions (oral leukoplakia and oral lichen planus).
Exclusion criteria
* Patients with OSMF * bleeding disorders and * other systemic diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number and Percentage of Lesions That Were Stained Positive | 2 weeks | outcome measure1 |
| Sensitivity and Specificity (Percentage of True Positives and True Negatives) | 2 weeks | sensitivity: Percentage of lesions stained positive with Toluidine blue stain that were also stained positive with Rose Bengal stain specificity: Percentage of lesions stained negative with Toluidine blue stain that were also stained negative with Rose Bengal stain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal | 2 weeks | this outcome measure was limited to the biopsied lesions.additionally, the intent of this outcome measure was only to study early detection of dysplasia in oral premalignant lesions using the Rose bengal stain. (no comparison between the two stains were intended ) |
Participant flow
Recruitment details
patients were recruited from the outpatient department of the dental college where the study was conducted.
Pre-assignment details
3 patients were excluded as one patient had not quit the habit and in another patient the lesion regressed during 2 weeks waiting period post habit cessation
Participants by arm
| Arm | Count |
|---|---|
| All Study Participants All study participants received Rose Bengal and Toulidine Blue. Patients were asked to rinse their mouth with distilled water for 1 minute. 1% RB solution was applied with a cotton tip for 2 minutes. Again patients were asked to rinse their mouth for 1 minute with distilled water to remove excess RB solution and the area which had taken up the stain was photographed. Following this, patients were asked to rinse their mouth with 1% acetic acid for 1 min to remove the remaining RB stain from the lesion and were prepared for TB staining. 1% Toluidine blue was applied over the same lesion and after 30 seconds patients were made to swish with 1% acetic acid and the area stained was photographed. | 25 |
| All Study Participants All study participants received Rose Bengal and Toulidine Blue. Patients were asked to rinse their mouth with distilled water for 1 minute. 1% RB solution was applied with a cotton tip for 2 minutes. Again patients were asked to rinse their mouth for 1 minute with distilled water to remove excess RB solution and the area which had taken up the stain was photographed. Following this, patients were asked to rinse their mouth with 1% acetic acid for 1 min to remove the remaining RB stain from the lesion and were prepared for TB staining. 1% Toluidine blue was applied over the same lesion and after 30 seconds patients were made to swish with 1% acetic acid and the area stained was photographed. | 38 |
| Total | 63 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | lesion disappeared after stopping habit | 1 |
| Overall Study | Protocol Violation | 1 |
Baseline characteristics
| Characteristic | All Study Participants |
|---|---|
| Age, Categorical <=18 years | 0 lesions |
| Age, Categorical >=65 years | 0 lesions |
| Age, Categorical Between 18 and 65 years | 38 lesions |
| Age, Continuous | 38.16 years STANDARD_DEVIATION 9.6 |
| location of the lesion buccal mucosa | 31 lesions |
| location of the lesion gingiva | 1 lesions |
| location of the lesion labial mucosa | 5 lesions |
| location of the lesion tongue | 1 lesions |
| Sex: Female, Male Female | 6 lesions |
| Sex: Female, Male Male | 32 lesions |
| tobacco habit | 36 lesions |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 25 | 0 / 25 |
| other Total, other adverse events | 0 / 25 | 0 / 25 |
| serious Total, serious adverse events | 0 / 25 | 0 / 25 |
Outcome results
Number and Percentage of Lesions That Were Stained Positive
outcome measure1
Time frame: 2 weeks
Population: patients diagnosed with premalignant lesions who consented to participate in the study
| Arm | Measure | Value (COUNT_OF_UNITS) |
|---|---|---|
| Rose Bengal Staining | Number and Percentage of Lesions That Were Stained Positive | 29 lesions |
| Toluidine Blue Staining | Number and Percentage of Lesions That Were Stained Positive | 28 lesions |
Sensitivity and Specificity (Percentage of True Positives and True Negatives)
sensitivity: Percentage of lesions stained positive with Toluidine blue stain that were also stained positive with Rose Bengal stain specificity: Percentage of lesions stained negative with Toluidine blue stain that were also stained negative with Rose Bengal stain
Time frame: 2 weeks
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Rose Bengal Staining | Sensitivity and Specificity (Percentage of True Positives and True Negatives) | sensitivity | 100 percentage of lesions |
| Rose Bengal Staining | Sensitivity and Specificity (Percentage of True Positives and True Negatives) | specificity | 90 percentage of lesions |
Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal
this outcome measure was limited to the biopsied lesions.additionally, the intent of this outcome measure was only to study early detection of dysplasia in oral premalignant lesions using the Rose bengal stain. (no comparison between the two stains were intended )
Time frame: 2 weeks
| Arm | Measure | Group | Value (COUNT_OF_UNITS) |
|---|---|---|---|
| Rose Bengal Staining | Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal | dysplasia present | 5 lesions |
| Rose Bengal Staining | Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal | dysplasia absent | 15 lesions |
| Rose Bengal Staining | Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal | squamous cell carcinoma | 1 lesions |